SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014737
Filing Date
2022-08-04
Accepted
2022-08-04 16:07:22
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-20220630.htm   iXBRL 10-Q 2767236
2 EX-31.1 ctmx-ex31_1.htm EX-31.1 20926
3 EX-31.2 ctmx-ex31_2.htm EX-31.2 21057
4 EX-32.1 ctmx-ex32_1.htm EX-32.1 14585
5 EX-32.2 ctmx-ex32_2.htm EX-32.2 14569
  Complete submission text file 0000950170-22-014737.txt   7851453

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctmx-20220630_lab.xml EX-101.LAB 326047
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctmx-20220630_cal.xml EX-101.CAL 33785
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctmx-20220630_def.xml EX-101.DEF 179122
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctmx-20220630.xsd EX-101.SCH 42738
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctmx-20220630_pre.xml EX-101.PRE 281500
53 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-20220630_htm.xml XML 1273368
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 221136533
SIC: 2834 Pharmaceutical Preparations